IP Library Granted Patent US 11,285,241
Granted Patent B2
US 11,285,241 · App. 16/506,144 · Granted Mar 29, 2022

Anti-microbial and osteointegration nanotextured surfaces

Inventors: Jeffrey Tyber (Breinigsville, PA); Rui J. Ferreira (Livingston, NJ); Chris Faresich (Easton, PA)
Assignee: Tyber Medical, LLC
A61L27/04A61B17/70A61B17/80A61B17/8095A61B90/94A61F2/28A61F2/30767A61F2/42A61F2/44A61F2/447A61F2/4455A61F2/4465A61F2/4603A61F2/4611A61L27/025A61L27/306A61B17/7059A61B17/8645A61B2090/037A61F2/30771A61F2002/2817A61F2002/2835A61F2002/3008A61F2002/30011A61F2002/30028A61F2002/3071A61F2002/3082A61F2002/3084A61F2002/3092A61F2002/3093A61F2002/30266A61F2002/30281A61F2002/30321A61F2002/30326A61F2002/30355A61F2002/30507A61F2002/30578A61F2002/30593A61F2002/30774A61F2002/30808A61F2002/30836A61F2002/30843A61F2002/4627A61F2310/00407A61F2310/00461A61F2310/00796A61L2400/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,285,241
App. No.
16/506,144
Granted
Mar 29, 2022
Kind
B2
Abstract

Disclosed is a medical device having a substrate having an exposed surface and a texture over at least part of the exposed surface. The texture includes a plurality of nanofeatures that inhibit bacterial adhesion on the surface and that also inhibit bacterial growth on the surface and have a size range between about 0.01 nanometers and about 1,000 nanometers. The texture can include a plurality of nanofeatures applied thereto such that the texture has a first particle size at a first location, a second particle size at a second location, and a gradient of particle size from the first particle size to the second particle size between the first location and the second location.

Claims (29)

1. A medical device comprising:

a substrate having an exposed surface; and

a texture over at least part of the exposed surface, the texture comprising a plurality of nanofeatures, the nanofeatures inhibiting bacterial adhesion on the surface,

wherein the nanofeatures are formed on the substrate, and

wherein the nanofeatures comprise a first size range on the substrate and a second size range, smaller than the first size range, on top of the first size.

2. The medical device according to claim 1 , wherein the nanofeatures promote osteointegration.

3. The medical device according to claim 1 , wherein the nanofeatures have a size range between about 0.1 nanometers and about 1,000 nanometers.

4. The medical device according to claim 3 , wherein the nanofeatures have a size range between about 20 nanometers and about 50 nanometers.

5. The medical device according to claim 3 , wherein the nanofeatures have a size range between about 0.1 nanometers and about 10 nanometers.

6. The medical device according to claim 1 , wherein the texture comprises an oxide.

7. The medical device according to claim 6 , wherein the oxide comprises a titanium oxide.

8. The medical device according to claim 1 , wherein the texture further comprises deposition of an oxide.

9. The medical device according to claim 8 , wherein the oxide comprises a titanium oxide.

10. The medical device according to claim 1 , wherein the nanofeatures are generally spherical in shape.

11. The medical device according to claim 1 , wherein the nanofeatures are irregularly shaped.

12. The medical device according to claim 1 , wherein the nanofeatures are generally elongated in shape.

13. The medical device according to claim 1 , wherein the nanofeatures are nanotubes.

14. The medical device according to claim 1 , wherein the texture further comprises a coating.

15. The medical device according to claim 1 , wherein the texture comprises a surface etching.

16. The medical device according to claim 1 , wherein the substrate comprises a metallic material.

17. The medical device according to claim 1 , wherein the substrate comprises a non-metallic material.

18. The medical device according to claim 1 , wherein the nanofeatures are randomly distributed on the substrate.

19. The medical device according to claim 1 , wherein the surface is texturized.

20. A medical device comprising:

a substrate having an exposed surface; and

a texture over at least part of the exposed surface, the texture comprising a plurality of nanofeatures, the nanofeatures inhibiting bacterial adhesion on the surface,

wherein the plurality of nanofeatures comprise a first plurality of nanoparticles having a first size range attached to the surface and a second plurality of nanoparticles having a second size range, different from the first size range, on top of the first plurality of nanoparticles.

21. The medical device according to claim 20 , wherein the first plurality of nanoparticles has a first shape and wherein the second plurality of nanoparticles has a second shape, different from the first shape.

22. The medical device according to claim 20 , wherein the first plurality of nanoparticles enhances osteoconductivity and wherein the second plurality of nanoparticles enhances anti-bacterial properties.

Assignments (2)
SECURITY INTEREST Recorded Jun 12, 2025
From: PIONEER SURGICAL TECHNOLOGY, INC.; TYBER MEDICAL LLC; SMADE SAS; BRADSHAW MEDICAL INC.; TURNER MEDICAL, INC.; IN’TECH MEDICAL SAS
To: OHA AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 071575/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2024
From: TYBER, JEFFREY; FERREIRA, RUI; FARESICH, CHRISTOPHER
To: TYBER MEDICAL LLC
Reel/Frame 068102/0727 →
Continuity (5)
Continuation 15162657 · May 24, 2016
Continuation In Part 14513300 · Oct 14, 2014
Continuation In Part 14054100 · Oct 15, 2013
Provisional Application 61715891 · Oct 19, 2012
Related Publication 20190328928A1 · Oct 31, 2019
Cited By (1)
US 12,605,488